In the interest of patients who benefit from therapeutic breakthroughs, MolecularMD continually seeks to partner with healthcare organizations and drug development companies that are involved in the development of targeted cancer treatments. As a collaborator, partner or service provider, we can help accelerate translational medicine to the clinic by providing world class assay development, optimization, and validation all supported by prominent clinical researchers.
Please contact our Business Development professionals to discuss collaborative or partnering opportunities.